drugset / Trial / NCT01617239
Clinical Study for Safety and Immunogenicity Study of Influenza Vaccine
RandomizedParallel-groupOpen-labelPrevention
Summary
The goal of the study is to assess the safety and immune response after vaccination with different doses and vaccination schedules of virosomal influenza vaccine.
Timeline
- Start
- 2012-06
- Primary completion
- 2013-06
- Completion
- 2013-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Inflexal V | Vaccine | 0.5 ml | Intramuscular |
| Subject | Inflexal V | Vaccine | 1 ml | Intramuscular |
| Subject | Inflexal V | Vaccine | 1.5 ml | Intramuscular |